GlassScriptPhysician profile
Suman Golla
NPI 1245203876
$13,434.86
in general payments reported to CMS, 2019-2025
11 companies · $1,980 in 2025
The $1,980 reported for 2025 was more than what 89% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,223 · 2020: $16.64 · 2021: $2,891 · 2022: $23.83 · 2023: $61.50 · 2024: $238 · 2025: $1,980.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,950 · Food and Beverage: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,950.00 |
| Food and Beverage | $329.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $12,553.81 | 2019-2025 | Tezspire |
| Optinose US, INC. | $274.96 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $148.55 | 2019-2021 | |
| Next Science LLC | $123.57 | 2021 | |
| Urgo Medical North America, LLC | $82.16 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $61.50 | 2023 | Lifevest |
| Phadia US INC. | $53.76 | 2024 | Immunocap |
| Convatec INC. | $52.27 | 2024 | |
| Mimedx Group, INC. | $49.83 | 2024 | |
| Mayne Pharma Commercial LLC | $20.01 | 2025 | |
| Alk-Abello, INC | $14.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suman Golla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.